EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Treatment of congenital cytomegalovirus infection

Gyu Hong Shim

Clinical and Experimental Pediatrics · 15.09.2023 · 66 (9) · 384-394

DOI: 10.3345/cep.2022.01032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Pediatrics, erschienen am 15.09.2023. Verfasst von Gyu Hong Shim. Beteiligte Einrichtung: Department of Pediatrics, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Congenital cytomegalovirus (CMV) is the most common cause of congenital infection worldwide, the most common nongenetic cause of sensorineural hearing loss in children, and a cause of neurodevelopmental disorders in the brain. Infants with symptomatic congenital CMV infection may benefit from hearing and neurodevelopmental outcomes, particularly if antiviral treatment is initiated within the first month of life. Infants with life-threatening symptoms are recommended to receive 2–6 weeks of intravenous ganciclovir and then switch to oral valganciclovir, and those without life-threatening symptoms are recommended to use oral valganciclovir during the entire 6-month period. During antiviral drug treatment, absolute neutrophil count, platelet count, blood urea nitrogen, creatinine, and liver function tests were performed to identify neutropenia, thrombocytopenia, renal failure, and liver failure. This review investigated the evidence to date of treating congenital CMV infection.

Schlagwörter

Stichwörter der Autor:innen

CongenitalCytomegalovirus infectionsGanciclovirSensorineural hearing lossValganciclovir

Autor:innen und Institutionen

  • Department of Pediatrics, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.

Zitieren

APA

Shim, G. H. (2023). Treatment of congenital cytomegalovirus infection. Clinical and Experimental Pediatrics, 66(9), 384-394. https://doi.org/10.3345/cep.2022.01032

Vancouver

Shim GH. Treatment of congenital cytomegalovirus infection. Clinical and Experimental Pediatrics. 2023;66(9):384-394. doi:10.3345/cep.2022.01032

BibTeX
@article{Shim2023,
  author = {Shim, Gyu Hong},
  title = {Treatment of congenital cytomegalovirus infection},
  journal = {Clinical and Experimental Pediatrics},
  year = {2023},
  volume = {66},
  number = {9},
  pages = {384--394},
  doi = {10.3345/cep.2022.01032}
}
Kostenlos starten →